Improved Survival in Europe
Findings from a retrospective observational study that included patients diagnosed with haematological malignancies from 20 European countries showed that survival increased for most haematological malignancies.
The investigators analysed 560,444 cases from 30 cancer registries that had continuous incidence as well as good quality data from 1992 to 2007. The largest increases in survival were seen for diffuse large B-cell lymphoma (42.0% [95% CI 40.7-43.4] to 55.4% [54.6-56.2], p<0.0001) and follicular lymphoma (58.9% [57.3-60.6] to 74.3% [72.9-75.5], p<0.0001). The widespread use of newer and more effective therapies likely accounts for the improvement seen in survival. For more information, click here.